Kadimastem - Stem Cell to Cure Diseases

About Us > Company Profile

Kadimastem is a leading regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders.

The company’s proprietary technologies and know-how enable the differentiation of stem cells into insulin secreting beta cells as well as a range of neural cells (including Oligodendrocytes, Astrocytes).  Based on its differentiation technologies, the company is advancing two  therapeutic programs focused on diabetes mellitus and ALS, where stem cells are differentiated into beta cells (for the diabetes program) and astrocytes (for the ALS program) with the goal of implanting them into patients, and affecting diseases progression.